Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope Share
CLICK HERE TO SHARE YOUR STORY!
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
Menu
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
  • Join PW

1467 Search Results Found

You searched for: "study of the week"
  1. Home>
  2. Search results for “study of the week”>
  3. Page 85
Improving NAFLD and NASH Outcomes Through Novel Drug and Histologic Spectrum Focus

Improving NAFLD and NASH Outcomes Through Novel Drug and Histologic Spectrum Focus

  According to a recent article from Physician’s Weekly, two trials recently published are showing the results of striving to improve the management and outcomes in nonalcoholic steatohepatitis (NASH) and…

Continue Reading Improving NAFLD and NASH Outcomes Through Novel Drug and Histologic Spectrum Focus
This Really is a BIG BANG for Dystrophic Epidermolysis Bullosa

This Really is a BIG BANG for Dystrophic Epidermolysis Bullosa

CONTENT WARNING: Severe skin wounds and damage Working in rare disease is always  hard- It means working in suffering and grief, but even with all our experience, we had to…

Continue Reading This Really is a BIG BANG for Dystrophic Epidermolysis Bullosa
Post-COVID Syndrome is Very Similar To Chronic Fatigue Syndrome

Post-COVID Syndrome is Very Similar To Chronic Fatigue Syndrome

Even as COVID-19 cases die down, post-COVID syndrome still plagues many individuals across the world. These individuals have faced ongoing COVID-19 symptoms for more than two weeks following diagnosis. The…

Continue Reading Post-COVID Syndrome is Very Similar To Chronic Fatigue Syndrome
CRISPR/Cas9 Technology May Be the First Treatment to Cure ATTR Amyloidosis

CRISPR/Cas9 Technology May Be the First Treatment to Cure ATTR Amyloidosis

CRISPR Cas9 gene editing is still looked upon as a new phenomenon in medicine. Yet it appears in the news almost every week. This week Neurology Today shines a light…

Continue Reading CRISPR/Cas9 Technology May Be the First Treatment to Cure ATTR Amyloidosis
Editor’s Choice: The 2021 Patient Worthy Reader Survey

Editor’s Choice: The 2021 Patient Worthy Reader Survey

Happy Friday! This week, we'd like to get to know more about you! Fill out the 2021 Patient Worthy Reader's Survey and let us know the reasons you come to…

Continue Reading Editor’s Choice: The 2021 Patient Worthy Reader Survey
 Compassion Corner: Clinical Trial Participants Give Doctors Lower Scores Based on Delivery of Unfavorable Diagnoses

 Compassion Corner: Clinical Trial Participants Give Doctors Lower Scores Based on Delivery of Unfavorable Diagnoses

Compassion [kuhm-pash-uhn] noun A feeling of deep sympathy and sorrow for another who is stricken by misfortune, accompanied by a strong desire to alleviate the suffering. Compassion Corner is a…

Continue Reading  Compassion Corner: Clinical Trial Participants Give Doctors Lower Scores Based on Delivery of Unfavorable Diagnoses
A Drug Shows Amyloid Reduction in Early Alzheimer’s

A Drug Shows Amyloid Reduction in Early Alzheimer’s

According to a recent article in Biospace, Eisai Pharmaceutical and Biogen Biotechnology recently announced updates to their Phase IIB study 201 and a five-year open-label extension (OLE) studies using lecanemab…

Continue Reading A Drug Shows Amyloid Reduction in Early Alzheimer’s
Durvalumab Hopes to be Treatment Option for Malignant Pleural Mesothelioma

Durvalumab Hopes to be Treatment Option for Malignant Pleural Mesothelioma

According to a recent article from OncologyLive, investigators are looking at durvalumab to aid in the treatment of adults with malignant pleural mesothelioma in the Phase 3 DREAM3R Trial. Malignant…

Continue Reading Durvalumab Hopes to be Treatment Option for Malignant Pleural Mesothelioma
  • Go to the previous page
  • 1
  • …
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • …
  • 184
  • Go to the next page
Finding Light Through Story-The Power of Ambassadorship in the Endometrial Cancer Community
*cancer that cannot be removed with surgery or has spread to other parts of the body. GEJ= gastroesophageal junction (where the esophagus joins the stomach)
CLICK HERE TO SHARE YOUR STORY!
We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.
Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Partner With Us
Submit a Story

Keep Up to Date

Subscribe to Our Newsletter
Check Out Rare Events
Get Inspired By Our Memes

Learn More

About Us
Rare Diseases and Conditions
Terms of Use
Privacy Notice
Privacy Policy for CA Residents
EU/UK Privacy Notice
Data Privacy Framework: Consumer Privacy Policy
Consumer Health Data Privacy Policy
Cookie Notice

Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope

© Copyright 2024 Patient Worthy

Sign Up With a Patient Worthy Account and Share Your Rare Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info

We're Happy You're Here!

What best describes you when it comes to rare disease? (check all that apply)

What rare disease(s)/conditions are most important to you?

Visit Home Page or

Thank you for signing up for a Patient Worthy Account!

Have a rare disease story to share? Let us know

Share Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info